Technetium: profile and news






DRAXIS Health Reports Results for the First Quarter of 2006  May 11, 2006
One key near term program is the development of Sestamibi, a lyophilized product widely used for Technetium-based cardiac imaging studies, a market segment not ... - Yahoo! News (press release)

Contamination in Irish Sea 'could last for decades'  Apr 19, 2006
A by-product known as Technetium 99 is contaminating the sea water and it could be many years before it is completely clear of the toxin. ... - Belfast Telegraph,

Prostate Cancer: EAU Highlights on Recent Findings  May 11, 2006
...patients undergoing radical prostatectomy. In this study, technetium-99m nanocolloid was injected into the prostate. Image fusion of ... - Medscape (subscription)

Scanning pinpoints adenoma  Apr 30, 2006
Patients can be injected with a radioactive isotope called Technetium Sestamibi. This is concentrated in the parathyroid glands. ... - Orlando Sentinel,

Source: Boston Life Sciences, Inc.  May 8, 2006
...programs include Inosine for the treatment of stroke, a DAT blocker for the treatment of Parkinson's disease and a second generation technetium-based molecular ... - Yahoo! News (press release)

Immunomedics develops novel protein technology  Apr 26, 2006
Pretargeting studies using TF2 and a technetium-99m-labeled HSG-radiotracer in a CEA-expressing human colon cancer growing in mice demonstrated that 30% of ... - Pharmaceutical Business Review

New findings in the area of imaging described  Apr 24, 2006
AR Galassi and colleagues at the University of Catania wrote, "In 322 consecutive patients (mean age 61±10 years), exercise technetium-99m-tetrofosmin single ... - Therapeutics Daily (subscription) (press release),

Monitoring Cancer Treatment Response With PET, Part 1  Apr 27, 2006
...stromal tumors. [3]. Fluorine-18 (F-18) is to PET as technetium-99m (Tc-99m) is to SPECT and conventional nuclear medicine. Currently, F ... - Medscape (subscription)

Contrast echo is more accurate than gated SPECT for LV remodeling ...  Apr 24, 2006
..."We aimed to evaluate the accuracy of CE to assess LV remodeling after AMI compared with technetium-99m sestamibi gated single photon emission computed ... - Therapeutics Daily (subscription) (press release),

Bristol-Myers Squibb Company Reports First Quarter 2006 Financial ...  Apr 27, 2006
25% to $181 million in the first quarter of 2006 from $145 million in the same period in 2005, primarily due to strong growth of Technetium Tc99m Generators ... - Yahoo! News (press release)

Immunomedics and IBC Pharmaceuticals Report on a Novel Protein ...  Apr 25, 2006
Pretargeting studies reported in this PNAS article using TF2 and a technetium-99m-labeled HSG-radiotracer in a CEA-expressing human colon cancer growing in ... - Yahoo! News (press release)


Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org